基本信息
浏览量:1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
In July 2023, I joined Dept Pharmaceutical & Administrative Sciences at Western New England University, College of Pharmacy & Health Sciences.
Since my time at Dept Pharmacology and Toxicology at University of Louisville School of Medicine between 2018 and 2023, I have been working closely with Dr. David W. Hein, who is a leading expert in arylamine N-acetyltransferase (NAT) biology. My current research efforts are focused on 1) contribution of NAT1 to breast cancer growth and metastasis, 2) the role of human NAT2 in cellular metabolism and insulin sensitivity in hepatocytes; 3) the novel link between dietary exposure to heterocyclic amines (HCAs) and development of insulin resistance; and most recently 4) the bladder cancer risk allele of NAT2, rs1495741.
研究兴趣
论文共 67 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FEBS open bio (2024)
CARDIOVASCULAR TOXICOLOGYno. 8 (2024): 747-756
Archives of toxicologyno. 6 (2023): 1613-1626
Pharmacogenetics and genomicsno. 6 (2023): 136-137
Toxicology letters (2023): 192-195
Biomedicinesno. 7 (2023): 2066-2066
Toxicological sciences : an official journal of the Society of Toxicologyno. 2 (2022): 158-172
Cancer Researchno. 12_Supplement (2022): 4037-4037
加载更多
作者统计
#Papers: 68
#Citation: 3904
H-Index: 24
G-Index: 50
Sociability: 6
Diversity: 3
Activity: 14
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn